AngioDynamics, Inc. (ANGO)

AngioDynamics Income Statement

Financials in millions USD. Fiscal year is June - May.

Year	2023	2022	2021	2020	2019
Revenue	338.75	316.22	291.01	264.16	270.63
Revenue Growth (YoY)	7.13%	8.66%	10.17%	-2.39%	3.43%
Cost of Revenue	164.51	150.49	134.22	113.89	114.63
Gross Profit	174.25	165.73	156.79	150.27	156
Selling, General & Admin	144.25	133.75	117.22	116.51	111.73
Research & Development	29.88	30.74	36.39	29.68	28.26
Other Operating Expenses	49.53	29.29	38.28	182.84	32.39
Operating Expenses	223.66	193.78	191.89	329.03	172.38
Operating Income	-49.42	-28.05	-35.1	-178.76	-16.38
Interest Expense / Income	2.7	0.69	0.86	0.91	5.1
Other Expense / Income	2.32	1.21	0.09	-11.53	-79.26
Pretax Income	-54.44	-29.95	-36.05	-168.14	57.78
Income Tax	-2	-3.4	-4.5	-1.35	-3.56
Net Income	-52.44	-26.55	-31.55	-166.79	61.34
Net Income Growth	-	-	-	-	275.51%
Shares Outstanding (Basic)	39	39	38	38	37
Shares Outstanding (Diluted)	39	39	38	38	37
Shares Change	1.21%	1.74%	1.00%	1.27%	1.11%
EPS (Basic)	-1.33	-0.68	-0.82	-4.39	1.64
EPS (Diluted)	-1.33	-0.68	-0.82	-4.39	1.64
EPS Growth	-	-	-	-	272.73%
Free Cash Flow	-9.13	-22.9	10.38	-21.79	34.32
Free Cash Flow Per Share	-0.23	-0.59	0.27	-0.57	0.92
Gross Margin	51.44%	52.41%	53.88%	56.89%	57.64%
Operating Margin	-14.59%	-8.87%	-12.06%	-67.67%	-6.05%
Profit Margin	-15.48%	-8.40%	-10.84%	-63.14%	22.67%
Free Cash Flow Margin	-2.69%	-7.24%	3.57%	-8.25%	12.68%
Effective Tax Rate	-	-	-	-	-6.15%
EBITDA	-18.38	2.53	-6.82	-141.35	88.76
EBITDA Margin	-5.43%	0.80%	-2.34%	-53.51%	32.80%
Depreciation & Amortization	33.36	31.79	28.37	25.88	25.88
EBIT	-51.74	-29.26	-35.19	-167.23	62.88
EBIT Margin	-15.27%	-9.25%	-12.09%	-63.31%	23.24%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).